カテゴリ： 世界, 医療/バイオ, QYResearch

抗生物質の世界市場2023年：ペニシリン、アミノグリコシド、テトラサイクリン、クロラムフェニコール、マクロライド、その他

■ 英語タイトル：Global Antibiotic Drug Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8669）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8669
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：100
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[抗生物質の世界市場2023年：ペニシリン、アミノグリコシド、テトラサイクリン、クロラムフェニコール、マクロライド、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は抗生物質のグローバル市場について調査・分析し、世界の抗生物質市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（ペニシリン、アミノグリコシド、テトラサイクリン、クロラムフェニコール、マクロライド、その他）、用途別セグメント分析（病院、診療所）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Pfizer、Abbvie、Novartis AG、Merck & Co. Inc、GlaxoSmithKline、Apotex、Hanmi Cepha Plant、Globela Pharma、Bausch Health、Teva Pharmaceutical Industries Limited、Bristol-Myers Squibb Company、Mylan、Sanofi、ACS Dobfar S.p.A、Spero Therapeutics、Savior Lifetecなどが含まれています。抗生物質のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、抗生物質市場規模を算出する際に考慮しました。

・抗生物質市場の概要
- 抗生物質の種類別セグメント
- 世界の抗生物質市場規模：タイプ別分析（ペニシリン、アミノグリコシド、テトラサイクリン、クロラムフェニコール、マクロライド、その他）
- 抗生物質の用途別セグメント
- 世界の抗生物質市場規模：用途別分析（病院、診療所）
- 世界の抗生物質市場規模予測（2018年-2029年）

・抗生物質市場の成長トレンド
- 抗生物質の地域別市場規模（2018年-2029年）
- 抗生物質市場ダイナミクス
- 抗生物質の業界動向
- 抗生物質市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：ペニシリン、アミノグリコシド、テトラサイクリン、クロラムフェニコール、マクロライド、その他
- 世界の抗生物質のタイプ別市場規模（2018年-2023年）
- 世界の抗生物質のタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院、診療所
- 世界の抗生物質の用途別市場規模（2018年-2023年）
- 世界の抗生物質の用途別市場規模（2024年-2029年）

・抗生物質の地域別市場規模
- 北米の抗生物質市場規模（2018年-2029年）
- 米国の抗生物質市場規模（2018年-2029年）
- ヨーロッパの抗生物質市場規模（2018年-2029年）
- アジア太平洋の抗生物質市場規模（2018年-2029年）
- 中国の抗生物質市場規模（2018年-2029年）
- 日本の抗生物質市場規模（2018年-2029年）
- 韓国の抗生物質市場規模（2018年-2029年）
- インドの抗生物質市場規模（2018年-2029年）
- オーストラリアの抗生物質市場規模（2018年-2029年）
- 中南米の抗生物質市場規模（2018年-2029年）
- 中東・アフリカの抗生物質市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Pfizer、Abbvie、Novartis AG、Merck & Co. Inc、GlaxoSmithKline、Apotex、Hanmi Cepha Plant、Globela Pharma、Bausch Health、Teva Pharmaceutical Industries Limited、Bristol-Myers Squibb Company、Mylan、Sanofi、ACS Dobfar S.p.A、Spero Therapeutics、Savior Lifetec

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Antibiotic Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Antibiotic Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Antibiotic Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Antibiotic Drug in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Antibiotic Drug include Pfizer, Abbvie, Novartis AG, Merck & Co. Inc, GlaxoSmithKline, Apotex, Hanmi Cepha Plant, Globela Pharma and Bausch Health, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Antibiotic Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibiotic Drug.
The Antibiotic Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Antibiotic Drug market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibiotic Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Pfizer
Abbvie
Novartis AG
Merck & Co. Inc
GlaxoSmithKline
Apotex
Hanmi Cepha Plant
Globela Pharma
Bausch Health
Teva Pharmaceutical Industries Limited
Bristol-Myers Squibb Company
Mylan
Sanofi
ACS Dobfar S.p.A
Spero Therapeutics
Savior Lifetec
Segment by Type
Penicillins
Aminoglycosides
Tetracyclines
Chloramphenicol
Macrolides
Others
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibiotic Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibiotic Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Penicillins
1.2.3 Aminoglycosides
1.2.4 Tetracyclines
1.2.5 Chloramphenicol
1.2.6 Macrolides
1.2.7 Others
1.3 Market by Application
1.3.1 Global Antibiotic Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antibiotic Drug Market Perspective (2018-2029)
2.2 Antibiotic Drug Growth Trends by Region
2.2.1 Global Antibiotic Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Antibiotic Drug Historic Market Size by Region (2018-2023)
2.2.3 Antibiotic Drug Forecasted Market Size by Region (2024-2029)
2.3 Antibiotic Drug Market Dynamics
2.3.1 Antibiotic Drug Industry Trends
2.3.2 Antibiotic Drug Market Drivers
2.3.3 Antibiotic Drug Market Challenges
2.3.4 Antibiotic Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antibiotic Drug Players by Revenue
3.1.1 Global Top Antibiotic Drug Players by Revenue (2018-2023)
3.1.2 Global Antibiotic Drug Revenue Market Share by Players (2018-2023)
3.2 Global Antibiotic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antibiotic Drug Revenue
3.4 Global Antibiotic Drug Market Concentration Ratio
3.4.1 Global Antibiotic Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibiotic Drug Revenue in 2022
3.5 Antibiotic Drug Key Players Head office and Area Served
3.6 Key Players Antibiotic Drug Product Solution and Service
3.7 Date of Enter into Antibiotic Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antibiotic Drug Breakdown Data by Type
4.1 Global Antibiotic Drug Historic Market Size by Type (2018-2023)
4.2 Global Antibiotic Drug Forecasted Market Size by Type (2024-2029)
5 Antibiotic Drug Breakdown Data by Application
5.1 Global Antibiotic Drug Historic Market Size by Application (2018-2023)
5.2 Global Antibiotic Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Antibiotic Drug Market Size (2018-2029)
6.2 North America Antibiotic Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Antibiotic Drug Market Size by Country (2018-2023)
6.4 North America Antibiotic Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antibiotic Drug Market Size (2018-2029)
7.2 Europe Antibiotic Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Antibiotic Drug Market Size by Country (2018-2023)
7.4 Europe Antibiotic Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antibiotic Drug Market Size (2018-2029)
8.2 Asia-Pacific Antibiotic Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Antibiotic Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Antibiotic Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antibiotic Drug Market Size (2018-2029)
9.2 Latin America Antibiotic Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Antibiotic Drug Market Size by Country (2018-2023)
9.4 Latin America Antibiotic Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antibiotic Drug Market Size (2018-2029)
10.2 Middle East & Africa Antibiotic Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Antibiotic Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Antibiotic Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Antibiotic Drug Introduction
11.1.4 Pfizer Revenue in Antibiotic Drug Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 Abbvie
11.2.1 Abbvie Company Detail
11.2.2 Abbvie Business Overview
11.2.3 Abbvie Antibiotic Drug Introduction
11.2.4 Abbvie Revenue in Antibiotic Drug Business (2018-2023)
11.2.5 Abbvie Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Detail
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Antibiotic Drug Introduction
11.3.4 Novartis AG Revenue in Antibiotic Drug Business (2018-2023)
11.3.5 Novartis AG Recent Development
11.4 Merck & Co. Inc
11.4.1 Merck & Co. Inc Company Detail
11.4.2 Merck & Co. Inc Business Overview
11.4.3 Merck & Co. Inc Antibiotic Drug Introduction
11.4.4 Merck & Co. Inc Revenue in Antibiotic Drug Business (2018-2023)
11.4.5 Merck & Co. Inc Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Antibiotic Drug Introduction
11.5.4 GlaxoSmithKline Revenue in Antibiotic Drug Business (2018-2023)
11.5.5 GlaxoSmithKline Recent Development
11.6 Apotex
11.6.1 Apotex Company Detail
11.6.2 Apotex Business Overview
11.6.3 Apotex Antibiotic Drug Introduction
11.6.4 Apotex Revenue in Antibiotic Drug Business (2018-2023)
11.6.5 Apotex Recent Development
11.7 Hanmi Cepha Plant
11.7.1 Hanmi Cepha Plant Company Detail
11.7.2 Hanmi Cepha Plant Business Overview
11.7.3 Hanmi Cepha Plant Antibiotic Drug Introduction
11.7.4 Hanmi Cepha Plant Revenue in Antibiotic Drug Business (2018-2023)
11.7.5 Hanmi Cepha Plant Recent Development
11.8 Globela Pharma
11.8.1 Globela Pharma Company Detail
11.8.2 Globela Pharma Business Overview
11.8.3 Globela Pharma Antibiotic Drug Introduction
11.8.4 Globela Pharma Revenue in Antibiotic Drug Business (2018-2023)
11.8.5 Globela Pharma Recent Development
11.9 Bausch Health
11.9.1 Bausch Health Company Detail
11.9.2 Bausch Health Business Overview
11.9.3 Bausch Health Antibiotic Drug Introduction
11.9.4 Bausch Health Revenue in Antibiotic Drug Business (2018-2023)
11.9.5 Bausch Health Recent Development
11.10 Teva Pharmaceutical Industries Limited
11.10.1 Teva Pharmaceutical Industries Limited Company Detail
11.10.2 Teva Pharmaceutical Industries Limited Business Overview
11.10.3 Teva Pharmaceutical Industries Limited Antibiotic Drug Introduction
11.10.4 Teva Pharmaceutical Industries Limited Revenue in Antibiotic Drug Business (2018-2023)
11.10.5 Teva Pharmaceutical Industries Limited Recent Development
11.11 Bristol-Myers Squibb Company
11.11.1 Bristol-Myers Squibb Company Company Detail
11.11.2 Bristol-Myers Squibb Company Business Overview
11.11.3 Bristol-Myers Squibb Company Antibiotic Drug Introduction
11.11.4 Bristol-Myers Squibb Company Revenue in Antibiotic Drug Business (2018-2023)
11.11.5 Bristol-Myers Squibb Company Recent Development
11.12 Mylan
11.12.1 Mylan Company Detail
11.12.2 Mylan Business Overview
11.12.3 Mylan Antibiotic Drug Introduction
11.12.4 Mylan Revenue in Antibiotic Drug Business (2018-2023)
11.12.5 Mylan Recent Development
11.13 Sanofi
11.13.1 Sanofi Company Detail
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Antibiotic Drug Introduction
11.13.4 Sanofi Revenue in Antibiotic Drug Business (2018-2023)
11.13.5 Sanofi Recent Development
11.14 ACS Dobfar S.p.A
11.14.1 ACS Dobfar S.p.A Company Detail
11.14.2 ACS Dobfar S.p.A Business Overview
11.14.3 ACS Dobfar S.p.A Antibiotic Drug Introduction
11.14.4 ACS Dobfar S.p.A Revenue in Antibiotic Drug Business (2018-2023)
11.14.5 ACS Dobfar S.p.A Recent Development
11.15 Spero Therapeutics
11.15.1 Spero Therapeutics Company Detail
11.15.2 Spero Therapeutics Business Overview
11.15.3 Spero Therapeutics Antibiotic Drug Introduction
11.15.4 Spero Therapeutics Revenue in Antibiotic Drug Business (2018-2023)
11.15.5 Spero Therapeutics Recent Development
11.16 Savior Lifetec
11.16.1 Savior Lifetec Company Detail
11.16.2 Savior Lifetec Business Overview
11.16.3 Savior Lifetec Antibiotic Drug Introduction
11.16.4 Savior Lifetec Revenue in Antibiotic Drug Business (2018-2023)
11.16.5 Savior Lifetec Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Antibiotic Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Penicillins
Table 3. Key Players of Aminoglycosides
Table 4. Key Players of Tetracyclines
Table 5. Key Players of Chloramphenicol
Table 6. Key Players of Macrolides
Table 7. Key Players of Others
Table 8. Global Antibiotic Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Antibiotic Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 10. Global Antibiotic Drug Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Antibiotic Drug Market Share by Region (2018-2023)
Table 12. Global Antibiotic Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 13. Global Antibiotic Drug Market Share by Region (2024-2029)
Table 14. Antibiotic Drug Market Trends
Table 15. Antibiotic Drug Market Drivers
Table 16. Antibiotic Drug Market Challenges
Table 17. Antibiotic Drug Market Restraints
Table 18. Global Antibiotic Drug Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Antibiotic Drug Market Share by Players (2018-2023)
Table 20. Global Top Antibiotic Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibiotic Drug as of 2022)
Table 21. Ranking of Global Top Antibiotic Drug Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Antibiotic Drug Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Antibiotic Drug Product Solution and Service
Table 25. Date of Enter into Antibiotic Drug Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Antibiotic Drug Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Antibiotic Drug Revenue Market Share by Type (2018-2023)
Table 29. Global Antibiotic Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 30. Global Antibiotic Drug Revenue Market Share by Type (2024-2029)
Table 31. Global Antibiotic Drug Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Antibiotic Drug Revenue Market Share by Application (2018-2023)
Table 33. Global Antibiotic Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 34. Global Antibiotic Drug Revenue Market Share by Application (2024-2029)
Table 35. North America Antibiotic Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Antibiotic Drug Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Antibiotic Drug Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Antibiotic Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. Europe Antibiotic Drug Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Antibiotic Drug Market Size by Country (2024-2029) & (US$ Million)
Table 41. Asia-Pacific Antibiotic Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 42. Asia-Pacific Antibiotic Drug Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Antibiotic Drug Market Size by Region (2024-2029) & (US$ Million)
Table 44. Latin America Antibiotic Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Latin America Antibiotic Drug Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Antibiotic Drug Market Size by Country (2024-2029) & (US$ Million)
Table 47. Middle East & Africa Antibiotic Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 48. Middle East & Africa Antibiotic Drug Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Antibiotic Drug Market Size by Country (2024-2029) & (US$ Million)
Table 50. Pfizer Company Detail
Table 51. Pfizer Business Overview
Table 52. Pfizer Antibiotic Drug Product
Table 53. Pfizer Revenue in Antibiotic Drug Business (2018-2023) & (US$ Million)
Table 54. Pfizer Recent Development
Table 55. Abbvie Company Detail
Table 56. Abbvie Business Overview
Table 57. Abbvie Antibiotic Drug Product
Table 58. Abbvie Revenue in Antibiotic Drug Business (2018-2023) & (US$ Million)
Table 59. Abbvie Recent Development
Table 60. Novartis AG Company Detail
Table 61. Novartis AG Business Overview
Table 62. Novartis AG Antibiotic Drug Product
Table 63. Novartis AG Revenue in Antibiotic Drug Business (2018-2023) & (US$ Million)
Table 64. Novartis AG Recent Development
Table 65. Merck & Co. Inc Company Detail
Table 66. Merck & Co. Inc Business Overview
Table 67. Merck & Co. Inc Antibiotic Drug Product
Table 68. Merck & Co. Inc Revenue in Antibiotic Drug Business (2018-2023) & (US$ Million)
Table 69. Merck & Co. Inc Recent Development
Table 70. GlaxoSmithKline Company Detail
Table 71. GlaxoSmithKline Business Overview
Table 72. GlaxoSmithKline Antibiotic Drug Product
Table 73. GlaxoSmithKline Revenue in Antibiotic Drug Business (2018-2023) & (US$ Million)
Table 74. GlaxoSmithKline Recent Development
Table 75. Apotex Company Detail
Table 76. Apotex Business Overview
Table 77. Apotex Antibiotic Drug Product
Table 78. Apotex Revenue in Antibiotic Drug Business (2018-2023) & (US$ Million)
Table 79. Apotex Recent Development
Table 80. Hanmi Cepha Plant Company Detail
Table 81. Hanmi Cepha Plant Business Overview
Table 82. Hanmi Cepha Plant Antibiotic Drug Product
Table 83. Hanmi Cepha Plant Revenue in Antibiotic Drug Business (2018-2023) & (US$ Million)
Table 84. Hanmi Cepha Plant Recent Development
Table 85. Globela Pharma Company Detail
Table 86. Globela Pharma Business Overview
Table 87. Globela Pharma Antibiotic Drug Product
Table 88. Globela Pharma Revenue in Antibiotic Drug Business (2018-2023) & (US$ Million)
Table 89. Globela Pharma Recent Development
Table 90. Bausch Health Company Detail
Table 91. Bausch Health Business Overview
Table 92. Bausch Health Antibiotic Drug Product
Table 93. Bausch Health Revenue in Antibiotic Drug Business (2018-2023) & (US$ Million)
Table 94. Bausch Health Recent Development
Table 95. Teva Pharmaceutical Industries Limited Company Detail
Table 96. Teva Pharmaceutical Industries Limited Business Overview
Table 97. Teva Pharmaceutical Industries Limited Antibiotic Drug Product
Table 98. Teva Pharmaceutical Industries Limited Revenue in Antibiotic Drug Business (2018-2023) & (US$ Million)
Table 99. Teva Pharmaceutical Industries Limited Recent Development
Table 100. Bristol-Myers Squibb Company Company Detail
Table 101. Bristol-Myers Squibb Company Business Overview
Table 102. Bristol-Myers Squibb Company Antibiotic Drug Product
Table 103. Bristol-Myers Squibb Company Revenue in Antibiotic Drug Business (2018-2023) & (US$ Million)
Table 104. Bristol-Myers Squibb Company Recent Development
Table 105. Mylan Company Detail
Table 106. Mylan Business Overview
Table 107. Mylan Antibiotic Drug Product
Table 108. Mylan Revenue in Antibiotic Drug Business (2018-2023) & (US$ Million)
Table 109. Mylan Recent Development
Table 110. Sanofi Company Detail
Table 111. Sanofi Business Overview
Table 112. Sanofi Antibiotic Drug Product
Table 113. Sanofi Revenue in Antibiotic Drug Business (2018-2023) & (US$ Million)
Table 114. Sanofi Recent Development
Table 115. ACS Dobfar S.p.A Company Detail
Table 116. ACS Dobfar S.p.A Business Overview
Table 117. ACS Dobfar S.p.A Antibiotic Drug Product
Table 118. ACS Dobfar S.p.A Revenue in Antibiotic Drug Business (2018-2023) & (US$ Million)
Table 119. ACS Dobfar S.p.A Recent Development
Table 120. Spero Therapeutics Company Detail
Table 121. Spero Therapeutics Business Overview
Table 122. Spero Therapeutics Antibiotic Drug Product
Table 123. Spero Therapeutics Revenue in Antibiotic Drug Business (2018-2023) & (US$ Million)
Table 124. Spero Therapeutics Recent Development
Table 125. Savior Lifetec Company Detail
Table 126. Savior Lifetec Business Overview
Table 127. Savior Lifetec Antibiotic Drug Product
Table 128. Savior Lifetec Revenue in Antibiotic Drug Business (2018-2023) & (US$ Million)
Table 129. Savior Lifetec Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antibiotic Drug Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Antibiotic Drug Market Share by Type: 2022 VS 2029
Figure 3. Penicillins Features
Figure 4. Aminoglycosides Features
Figure 5. Tetracyclines Features
Figure 6. Chloramphenicol Features
Figure 7. Macrolides Features
Figure 8. Others Features
Figure 9. Global Antibiotic Drug Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 10. Global Antibiotic Drug Market Share by Application: 2022 VS 2029
Figure 11. Hospital Case Studies
Figure 12. Clinic Case Studies
Figure 13. Antibiotic Drug Report Years Considered
Figure 14. Global Antibiotic Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Antibiotic Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Antibiotic Drug Market Share by Region: 2022 VS 2029
Figure 17. Global Antibiotic Drug Market Share by Players in 2022
Figure 18. Global Top Antibiotic Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibiotic Drug as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Antibiotic Drug Revenue in 2022
Figure 20. North America Antibiotic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Antibiotic Drug Market Share by Country (2018-2029)
Figure 22. United States Antibiotic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Antibiotic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Antibiotic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Antibiotic Drug Market Share by Country (2018-2029)
Figure 26. Germany Antibiotic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Antibiotic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Antibiotic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Antibiotic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Antibiotic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Antibiotic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Antibiotic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Antibiotic Drug Market Share by Region (2018-2029)
Figure 34. China Antibiotic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Antibiotic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Antibiotic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Antibiotic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Antibiotic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Antibiotic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Antibiotic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Antibiotic Drug Market Share by Country (2018-2029)
Figure 42. Mexico Antibiotic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Antibiotic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Antibiotic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Antibiotic Drug Market Share by Country (2018-2029)
Figure 46. Turkey Antibiotic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Antibiotic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Pfizer Revenue Growth Rate in Antibiotic Drug Business (2018-2023)
Figure 49. Abbvie Revenue Growth Rate in Antibiotic Drug Business (2018-2023)
Figure 50. Novartis AG Revenue Growth Rate in Antibiotic Drug Business (2018-2023)
Figure 51. Merck & Co. Inc Revenue Growth Rate in Antibiotic Drug Business (2018-2023)
Figure 52. GlaxoSmithKline Revenue Growth Rate in Antibiotic Drug Business (2018-2023)
Figure 53. Apotex Revenue Growth Rate in Antibiotic Drug Business (2018-2023)
Figure 54. Hanmi Cepha Plant Revenue Growth Rate in Antibiotic Drug Business (2018-2023)
Figure 55. Globela Pharma Revenue Growth Rate in Antibiotic Drug Business (2018-2023)
Figure 56. Bausch Health Revenue Growth Rate in Antibiotic Drug Business (2018-2023)
Figure 57. Teva Pharmaceutical Industries Limited Revenue Growth Rate in Antibiotic Drug Business (2018-2023)
Figure 58. Bristol-Myers Squibb Company Revenue Growth Rate in Antibiotic Drug Business (2018-2023)
Figure 59. Mylan Revenue Growth Rate in Antibiotic Drug Business (2018-2023)
Figure 60. Sanofi Revenue Growth Rate in Antibiotic Drug Business (2018-2023)
Figure 61. ACS Dobfar S.p.A Revenue Growth Rate in Antibiotic Drug Business (2018-2023)
Figure 62. Spero Therapeutics Revenue Growth Rate in Antibiotic Drug Business (2018-2023)
Figure 63. Savior Lifetec Revenue Growth Rate in Antibiotic Drug Business (2018-2023)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • テトラサイクリン系抗生物質の世界市場2023年：クロルテトラサイクリン、オキシテトラサイクリン、テトラサイクリン、メチルオキシテトラサイクリン、ドキシサイクリン、ミノサイクリン
  • 出血性疾患治療薬の世界市場2023年：経口式、静脈注射式、その他
  • 薬剤耐性結核治療薬の世界市場2023年：第一類抗結核薬、第二類抗結核薬、その他
  • 腫瘍溶解性ウイルス薬物治療の世界市場2023年：フェーズ1、フェーズ2、その他
  • 薬物乱用試験サービスの世界市場2023年：尿、唾液、毛髪、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8669 )"抗生物質の世界市場2023年：ペニシリン、アミノグリコシド、テトラサイクリン、クロラムフェニコール、マクロライド、その他" (英文：Global Antibiotic Drug Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。